JD O'Brien, JH Lium, JF Parosa, BR Deyoung, MR Wick and EP Trulock
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

The evolution of lung transplantation has offered an additional treatment option for patients with a variety of end-stage lung diseases, including some with systemic disorders. Lymphangiomyomatosis (LAM) is a multisystem disease of premenopausal women. The lung is the most frequently involved vital organ, and respiratory failure is the most common case of death. A small number of patients with LAM have undergone lung transplantation. This report describes a case of recurrent LAM in the allograft after single lung transplantation and discusses the implications of this finding.

This article has been cited by other articles:

				H. Mal, C. Guignabert, G. Thabut, M. P. d'Ortho, O. Brugiere, G. Dauriat, R. Marrash-Chahla, A.-S. Rangheard, G. Leseche, and M. Fournier Recurrence of Pulmonary Emphysema in an {alpha}-1 Proteinase Inhibitor-deficient Lung Transplant Recipient Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 811 - 814. [Abstract] [Full Text] [PDF]

				M. Karbowniczek, A. Astrinidis, B. R. Balsara, J. R. Testa, J. H. Lium, T. V. Colby, F. X. McCormack, and E. P. Henske Recurrent Lymphangiomyomatosis after Transplantation: Genetic Analyses Reveal a Metastatic Mechanism Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 976 - 982. [Abstract] [Full Text] [PDF]

				D. N. FRANZ, A. BRODY, C. MEYER, J. LEONARD, G. CHUCK, S. DABORA, G. SETHURAMAN, T. V. COLBY, D. J. KWIATKOWSKI, and F. X. MCCORMACK Mutational and Radiographic Analysis of Pulmonary Disease Consistent with Lymphangioleiomyomatosis and Micronodular Pneumocyte Hyperplasia in Women with Tuberous Sclerosis Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 661 - 668. [Abstract] [Full Text] [PDF]

				J. Collins, M. J. Hartman, T. F. Warner, N. L. Müller, E. A. Kazerooni, H. P. McAdams, R. M. Slone, and L. A. Parker Frequency and CT Findings of Recurrent Disease after Lung Transplantation Radiology, May 1, 2001; 219(2): 503 - 509. [Abstract] [Full Text]

				B. Paquette, P.-K. Fortier, J. Héroux, P. A Thibodeau, R. Wagner, J. Liu, and A. Cantin Oestrogen metabolism in lymphangioleiomyomatosis: catechol-O-methyltransferase pathway is not involved Thorax, July 1, 2000; 55(7): 574 - 578. [Abstract] [Full Text]

				S. Johnson Rare diseases bullet  1: Lymphangioleiomyomatosis: clinical features, management and basic mechanisms Thorax, March 1, 1999; 54(3): 254 - 264. [Full Text]

				J. Collins, N. L. Müller, E. A. Kazerooni, H. P. McAdams, A. N. Leung, and R. B. Love Lung Transplantation for Lymphangioleiomyomatosis: Role of Imaging in the Assessment of Complications Related to the Underlying Disease Radiology, February 1, 1999; 210(2): 325 - 332. [Abstract] [Full Text]

				F. A. Pigula, B. P. Griffith, M. A. Zenati, J. H. Dauber, S. A. Yousem, and R. J. Keenan Lung Transplantation for Respiratory Failure Resulting From Systemic Disease Ann. Thorac. Surg., December 1, 1997; 64(6): 1630 - 1634. [Abstract] [Full Text]

				B. ETIENNE, M. BERTOCCHI, J.-P. GAMONDES, F. THÉVENET, C. BOUDARD, T. WIESENDANGER, R. LOIRE, J. BRUNE, and J.-F. MORNEX Relapsing Pulmonary Langerhans Cell Histiocytosis after Lung Transplantation Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 288 - 291. [Full Text]

				A. Boehler, R. Speich, E. W. Russi, and W. Weder Lung Transplantation for Lymphangioleiomyomatosis N. Engl. J. Med., October 24, 1996; 335(17): 1275 - 1280. [Abstract] [Full Text] [PDF]